AIZ vs CRSP · P/E 15, rev $3.45B vs rev $11.6M
Assurant Inc (AIZ) versus Crispr Therapeutics AG (CRSP) — a side-by-side from cached financials, not a winner call.
Assurant Inc (AIZ) is a insurance - property & casualty company listed on US.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Latest reported AIZ revenue for 2026-06-30 was $3.45B. Net income was $298.6M. Revenue was up 1.0% from 2026-03-31 to 2026-06-30. AIZ currently screens at market cap $9.98B and trailing P/E 15.4.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
AIZ currently screens at market cap $9.98B and trailing P/E 15.4. CRSP currently screens at market cap $5.42B.
Not investment advice. Open the AIZ and CRSP stock pages for the full models.
Not investment advice.